Heparanase is highly expressed and regulates proliferation in GH-secreting pituitary tumor cells

Endocrinology

Volumn 152, Issue 12, 2011, Pages 4562-4570

  Rubinfeld, Hadara ^a,b   Cohen Kaplan, Victoria ^c   Nass, Dvora ^d   Ilan, Neta ^c   Meisel, Shilhav ^a,b   Cohen, Zvi R ^b,d   Hadani, Moshe ^b,d   Vlodavsky, Israel ^c   Shimon, Ilan ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^d SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; HEPARANASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN KINASE B; STEROID RECEPTOR COACTIVATOR 1; SYNAPTOPHYSIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; GENE SILENCING; GROWTH HORMONE SECRETING ADENOMA; HUMAN; HUMAN TISSUE; HYPOPHYSIS; IMMUNOHISTOCHEMISTRY; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCURONIDASE; GROWTH HORMONE; HUMANS; PITUITARY NEOPLASMS; RNA, MESSENGER;

EID: 82355163439     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-0273     Document Type: Article

References (41)

1. Vlodavsky I, Friedmann Y, Elkin M, Aingorn H, Atzmon R, Ishai- Michaeli R, Bitan M, Pappo O, Peretz T, Michal I, Spector L, Pecker I 1999 Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med 5:793-802 (Pubitemid 29318614)
2. Elkin M, Ilan N, Ishai-Michaeli R, Friedmann Y, Papo O, Pecker I, Vlodavsky I 2001 Heparanase as mediator of angiogenesis: mode of action. FASEB J 15:1661-1663
3. Vlodavsky I, Friedmann Y 2001 Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest 108:341-347 (Pubitemid 32730777)
4. Parish CR, Freeman C, Hulett MD 2001 Heparanase: a key enzyme involved in cell invasion. Biochim Biophys Acta 1471:M99-M108 (Pubitemid 32206686)
5. Vlodavsky I, Miao HQ, Medalion B, Danagher P, Ron D 1996 Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer Metastasis Rev 15:177-186 (Pubitemid 26236115)
6. Ilan N, Elkin M, Vlodavsky I 2006 Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Int J Biochem Cell Biol 38:2018-2039 (Pubitemid 44397619)
7. Vreys V, David G 2007 Mammalian heparanase: what is the message? J Cell Mol Med 11:427-452 (Pubitemid 47153456)
8. Nasser NJ 2008 Heparanase involvement in physiology and disease. Cell Mol Life Sci 65:1706-1715
9. Gingis-Velitski S, Zetser A, Flugelman MY, Vlodavsky I, Ilan N 2004 Heparanase induces endothelial cell migration via protein kinase B/Akt activation. J Biol Chem 279:23536-23541 (Pubitemid 38685666)
10. Goldshmidt O, Zcharia E, Cohen M, Aingorn H, Cohen I, Nadav L, Katz BZ, Geiger B, Vlodavsky I 2003 Heparanase mediates cell adhesion independent of its enzymatic activity. FASEB J 17:1015-1025 (Pubitemid 36676388)
11. Sotnikov I, Hershkoviz R, Grabovsky V, Ilan N, Cahalon L, Vlodavsky I, Alon R, Lider O 2004 Enzymatically quiescent heparanase augmentsTcell interactions with VCAM-1 and extracellular matrix components under versatile dynamic contexts. J Immunol 172: 5185-5193 (Pubitemid 38542014)
12. Zetser A, Bashenko Y, Miao HQ, Vlodavsky I, Ilan N 2003 Heparanase affects adhesive and tumorigenic potential of human glioma cells. Cancer Res 63:7733-7741 (Pubitemid 37466704)
13. Ben-Zaken O, Gingis-Velitski S, Vlodavsky I, Ilan N 2007 Heparanase induces Akt phosphorylation via a lipid raft receptor. Biochem Biophys Res Commun 361:829-834 (Pubitemid 47259014)
14. Nadir Y, Brenner B, Zetser A, Ilan N, Shafat I, Zcharia E, Goldshmidt O, Vlodavsky I 2006 Heparanase induces tissue factor expression in vascular endothelial and cancer cells. J Thromb Haemost 4:2443-2451 (Pubitemid 44575440)
15. Zetser A, Bashenko Y, Edovitsky E, Levy-Adam F, Vlodavsky I, Ilan N 2006 Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation. Cancer Res 66:1455-1463 (Pubitemid 43259926)
16. Cohen-Kaplan V, Doweck I, Naroditsky I, Vlodavsky I, Ilan N 2008 Heparanase augments epidermal growth factor receptor phosphorylation: correlation with head and neck tumor progression. Cancer Res 68:10077-10085
17. Farnoud MR, Farhadian F, Samuel JL, Derome P, Peillon F, Li JY 1995 Fibronectin isoforms are differentially expressed in normal and adenomatous human anterior pituitaries. Int J Cancer 61:27-34
18. Farnoud MR, Veirana N, Derome P, Peillon F, Li JY 1996 Adenomatous transformation of the human anterior pituitary is associated with alterations in integrin expression. Int J Cancer 67:45-53 (Pubitemid 26236068)
19. Páez Pereda M, Ledda MF, Goldberg V, Chervín A, Carrizo G, Molina H,Müller A, Renner U, Podhajcer O, Arzt E, Stalla GK 2000 High levels of matrix metalloproteinases regulate proliferation and hormone secretion in pituitary cells. J Clin Endocrinol Metab 85: 263-269 (Pubitemid 32268824)
20. Roelle S, Grosse R, Aigner A, Krell HW, Czubayko F, Gudermann T 2003 Matrix metalloproteinases 2 and 9 mediate epidermal growth factor receptor transactivation by gonadotropin-releasing hormone. J Biol Chem 278:47307-47318 (Pubitemid 37452320)
21. Zcharia E, Jia J, Zhang X, Baraz L, Lindahl U, Peretz T, Vlodavsky I, Li JP 2009 Newly generated heparanase knock-out mice unravel co-regulation of heparanase and matrix metalloproteinases. PLoS One 4:e5181
22. Zetser A, Levy-Adam F, Kaplan V, Gingis-Velitski S, Bashenko Y, Schubert S, Flugelman MY, Vlodavsky I, Ilan N 2004 Processing and activation of latent heparanase occurs in lysosomes. J Cell Sci 117:2249-2258 (Pubitemid 38807493)
23. Rubinfeld H, Hadani M, Barkai G, Taylor JE, Culler MD, Shimon I 2006 Cortistatin inhibits growth hormone release from human fetal and adenoma pituitary cells and prolactin secretion from cultured prolactinomas. J Clin Endocrinol Metab 91:2257-2263 (Pubitemid 43855015)
24. Doweck I, Kaplan-Cohen V, Naroditsky I, Sabo E, Ilan N, Vlodavsky I 2006 Heparanase localization and expression by head and neck cancer: correlation with tumor progression and patient survival. Neoplasia 8:1055-1061 (Pubitemid 44936155)
25. Goldshmidt O, Zcharia E, Aingorn H, Guatta-Rangini Z, Atzmon R, Michal I, Pecker I, Mitrani E, Vlodavsky I 2001 Expression pattern and secretion of human and chicken heparanase are determined by their signal peptide sequence. J Biol Chem 276:29178-29187
26. de la Torre NG, Wass JA, Turner HE 2004 Morphologic changes and molecular regulation of angiogenesis in pituitary adenomas. Front Horm Res 32:133-145
27. Cohen I, Pappo O, Elkin M, San T, Bar-Shavit R, Hazan R, Peretz T, Vlodavsky I, AbramovitchR2006 Heparanase promotes growth, angiogenesis and survival of primary breast tumors. Int J Cancer 118:1609-1617 (Pubitemid 43376422)
28. Joyce JA, Freeman C, Meyer-Morse N, Parish CR, Hanahan D 2005 A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer. Oncogene 24:4037-4051 (Pubitemid 40897051)
29. Jaffrain-Rea ML, Petrangeli E, Lubrano C, Minniti G, Di Stefano D, Sciarra F, Frati L, Tamburrano G, Cantore G, Gulino A 1998 Epidermal growth factor binding sites in human pituitary macroadenomas. J Endocrinol 158:425-433 (Pubitemid 28407550)
30. Kong YG, Ren ZY, Su CB, Wang RZ, Ma WB, Lian W 2004 Elevated soluble epidermal growth factor receptor level in pituitary adenoma and carcinoma. Chin Med Sci J 19:199-202 (Pubitemid 39362509)
31. LeRiche VK, Asa SL, Ezzat S 1996 Epidermal growth factor and its receptor (EGF-R) in human pituitary adenomas: EGF-R correlates with tumor aggressiveness. J Clin Endocrinol Metab 81:656-662 (Pubitemid 26055681)
32. Onguru O, Scheithauer BW, Kovacs K, Vidal S, Jin L, Zhang S, Ruebel KH, Lloyd RV 2004 Analysis of epidermal growth factor receptor and activated epidermal growth factor receptor expression in pituitary adenomas and carcinomas. Mod Pathol 17:772-780 (Pubitemid 38843359)
33. Theodoropoulou M, Arzberger T, Gruebler Y, Jaffrain-Rea ML, Schlegel J, Schaaf L, Petrangeli E, Losa M, Stalla GK, Pagotto U 2004 Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells. J Endocrinol 183:385-394 (Pubitemid 39562718)
34. Bromann PA, Korkaya H, Courtneidge SA 2004 The interplay between Src family kinases and receptor tyrosine kinases. Oncogene 23:7957-7968 (Pubitemid 39468854)
35. Fischer OM, Hart S, Gschwind A, Ullrich A 2003 EGFR signal transactivation in cancer cells. Biochem Soc Trans 31:1203-1208 (Pubitemid 38030939)
36. Haskell MD, Slack JK, Parsons JT, Parsons SJ 2001 c-Src tyrosine phosphorylation of epidermal growth factor receptor, P190 RhoGAP, and focal adhesion kinase regulates diverse cellular processes. Chem Rev 101:2425-2440 (Pubitemid 35373027)
37. Fux L, Ilan N, Sanderson RD, Vlodavsky I 2009 Heparanase: busy at the cell surface. Trends Biochem Sci 34:511-519
38. Shimon I, Hinton DR, Weiss MH, Melmed S 1998 Prolactinomas express human heparin-binding secretory transforming gene (hst) protein product: marker of tumour invasiveness. Clin Endocrinol (Oxf) 48:23-29 (Pubitemid 28122429)
39. Shimon I, Hüttner A, Said J, Spirina OM, Melmed S 1996 Heparinbinding secretory transforming gene (hst) facilitates rat lactotrope cell tumorigenesis and induces prolactin gene transcription. J Clin Invest 97:187-195 (Pubitemid 26022594)
40. Paez-Pereda M, Kuchenbauer F, Arzt E, Stalla GK 2005 Regulation of pituitary hormones and cell proliferation by components of the extracellular matrix. Braz J Med Biol Res 38:1487-1494 (Pubitemid 41440220)
41. Levy-Adam F, Ilan N, Vlodavsky I 2010 Tumorigenic and adhesive properties of heparanase. Semin Cancer Biol 20:153-160